交易 Recursion Pharmaceuticals, Inc. - RXRX CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.07 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Recursion Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
“B”分數表示相對 ESG 表現良好,公開報告重要 ESG 數據的透明度高於平均水平。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 7.37 | 0.09 | 1.24% | 7.28 | 7.54 | 7.26 |
Apr 17, 2024 | 7.44 | -0.15 | -1.98% | 7.59 | 7.67 | 7.40 |
Apr 16, 2024 | 7.53 | 0.00 | 0.00% | 7.53 | 7.74 | 7.49 |
Apr 15, 2024 | 7.75 | -0.61 | -7.30% | 8.36 | 8.42 | 7.74 |
Apr 12, 2024 | 8.38 | -0.42 | -4.77% | 8.80 | 8.89 | 8.28 |
Apr 11, 2024 | 8.90 | 0.27 | 3.13% | 8.63 | 8.90 | 8.49 |
Apr 10, 2024 | 8.53 | 0.00 | 0.00% | 8.53 | 8.74 | 8.39 |
Apr 9, 2024 | 9.07 | 0.14 | 1.57% | 8.93 | 9.19 | 8.92 |
Apr 8, 2024 | 8.96 | 0.09 | 1.01% | 8.87 | 9.08 | 8.76 |
Apr 5, 2024 | 8.85 | 0.41 | 4.86% | 8.44 | 8.91 | 8.39 |
Apr 4, 2024 | 8.69 | -0.31 | -3.44% | 9.00 | 9.29 | 8.68 |
Apr 3, 2024 | 8.90 | 0.15 | 1.71% | 8.75 | 9.31 | 8.70 |
Apr 2, 2024 | 8.72 | -0.18 | -2.02% | 8.90 | 8.91 | 8.64 |
Apr 1, 2024 | 9.34 | -0.55 | -5.56% | 9.89 | 9.92 | 9.30 |
Mar 28, 2024 | 9.92 | -0.09 | -0.90% | 10.01 | 10.25 | 9.91 |
Mar 27, 2024 | 10.14 | -0.15 | -1.46% | 10.29 | 10.34 | 10.04 |
Mar 26, 2024 | 10.29 | -0.31 | -2.92% | 10.60 | 10.84 | 10.28 |
Mar 25, 2024 | 10.49 | 0.02 | 0.19% | 10.47 | 10.87 | 10.38 |
Mar 22, 2024 | 10.44 | -0.04 | -0.38% | 10.48 | 10.76 | 10.26 |
Mar 21, 2024 | 10.61 | -0.61 | -5.44% | 11.22 | 11.41 | 10.23 |
Recursion Pharmaceuticals, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 6, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Recursion Pharmaceuticals Inc Earnings Release Q1 2024 Recursion Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 14, 2024 | ||
時間 (UTC) 18:00 | 國家 US
| 事件 Recursion Pharmaceuticals Inc Annual Shareholders Meeting Recursion Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Tuesday, August 6, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q2 2024 Recursion Pharmaceuticals Inc Earnings Release Q2 2024 Recursion Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
總收入 | 39.843 | 10.178 | 3.962 | 2.319 |
收入 | 39.843 | 10.178 | 3.962 | 2.319 |
總營業費用 | 285.57 | 193.78 | 89.46 | 65.315 |
銷售/一般/行政費用,總計 | 95.651 | 66.671 | 27.035 | 19.898 |
研究與開發 | 141.265 | 125.978 | 61.542 | 44.862 |
異常費用(收入) | 0 | 0.827 | 0.883 | 0.555 |
營業收入 | -245.727 | -183.602 | -85.498 | -62.996 |
利息收入(費用),非經營淨值 | 6.199 | -2.879 | -1.024 | 1.106 |
其他,淨值 | 0.052 | 0.002 | -0.484 | 0.011 |
稅前淨收入 | -239.476 | -186.479 | -87.006 | -61.879 |
稅後淨收入 | -239.476 | -186.479 | -87.006 | -61.879 |
未計算非常項目前的淨收益 | -239.476 | -186.479 | -87.006 | -61.879 |
淨收入 | -239.476 | -186.479 | -87.006 | -61.879 |
普通股股東可獲收益 (不含非經常性項目) | -239.476 | -186.479 | -87.006 | -61.879 |
普通股股東可獲收益 (含非經常性項目) | -239.476 | -186.479 | -87.006 | -61.879 |
攤薄淨收入 | -239.476 | -186.479 | -87.006 | -61.879 |
攤薄後加權平均股 | 175.537 | 125.348 | 162.155 | 162.155 |
扣除特別項目的每股攤薄盈利 | -1.36424 | -1.48769 | -0.53656 | -0.3816 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
每股正常攤薄盈利 | -1.36424 | -1.48109 | -0.53111 | -0.37818 |
Depreciation / Amortization | 0.379 | 0.304 | ||
收入成本,共計 | 48.275 | |||
毛利 | -8.432 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 11.017 | 12.134 | 13.676 | 13.16 | 7.674 |
收入 | 11.017 | 12.134 | 13.676 | 13.16 | 7.674 |
總營業費用 | 92.732 | 81.999 | 74.658 | 75.733 | 73.865 |
銷售/一般/行政費用,總計 | 28.29 | 21.674 | 23.356 | 19.488 | 18.399 |
研究與開發 | 53.46 | 46.525 | 40.311 | 40.76 | 38.363 |
Depreciation / Amortization | 1.6 | 0.152 | 0.151 | 0.076 | 0.076 |
營業收入 | -81.715 | -69.865 | -60.982 | -62.573 | -66.191 |
利息收入(費用),非經營淨值 | 4.931 | 4.641 | 3.669 | 1.82 | 0.638 |
稅前淨收入 | -76.726 | -65.327 | -57.492 | -60.445 | -65.56 |
稅後淨收入 | -76.726 | -65.327 | -57.492 | -60.445 | -65.56 |
未計算非常項目前的淨收益 | -76.726 | -65.327 | -57.492 | -60.445 | -65.56 |
淨收入 | -76.726 | -65.327 | -57.492 | -60.445 | -65.56 |
普通股股東可獲收益 (不含非經常性項目) | -76.726 | -65.327 | -57.492 | -60.445 | -65.56 |
普通股股東可獲收益 (含非經常性項目) | -76.726 | -65.327 | -57.492 | -60.445 | -65.56 |
攤薄淨收入 | -76.726 | -65.327 | -57.492 | -60.445 | -65.56 |
攤薄後加權平均股 | 196.561 | 191.618 | 185.781 | 173.436 | 172.212 |
扣除特別項目的每股攤薄盈利 | -0.39034 | -0.34092 | -0.30946 | -0.34851 | -0.38069 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.39034 | -0.33466 | -0.30946 | -0.34851 | -0.36443 |
異常費用(收入) | 1.2 | 0 | 0 | 2.8 | |
其他,淨值 | 0.058 | -0.103 | -0.179 | 0.308 | -0.007 |
收入成本,共計 | 9.382 | 12.448 | 10.84 | 15.409 | 14.227 |
毛利 | 1.635 | -0.314 | 2.836 | -2.249 | -6.553 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
流動資産總額 | 569.814 | 534.718 | 266.437 | 76.398 |
現金和短期投資 | 549.912 | 516.562 | 262.126 | 69.883 |
現金等價物 | 549.912 | 285.116 | 262.126 | 69.883 |
應收賬款總額,淨額 | 2.753 | 9.09 | 0.156 | 0.151 |
應收賬款 - 貿易,淨額 | 0 | 0.034 | 0.156 | 0.151 |
其他流動資産,總計 | 17.149 | 9.066 | 4.155 | 6.364 |
總資産 | 701.288 | 610.345 | 298.585 | 101.431 |
物業/廠房/設備,總計 - 淨額 | 121.447 | 64.725 | 25.967 | 24.37 |
物業/廠房/設備,總計 - 總額 | 151.562 | 83.462 | 35.929 | 30.085 |
累計折舊,總計 | -30.115 | -18.737 | -9.962 | -5.715 |
無形資産,淨額 | 1.306 | 1.385 | 1.689 | 0 |
其他長期資産,總計 | 7.92 | 8.716 | 3.691 | 0.663 |
流動負債總額 | 100.265 | 46.658 | 23.099 | 6.684 |
應付賬款 | 4.586 | 2.819 | 1.074 | 1.261 |
預提費用 | 38.856 | 33.749 | 10.952 | 5.346 |
應付票據/短期債務 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.097 | 0.09 | 1.073 | 0.077 |
其他流動負債,總計 | 56.726 | 10 | 10 | 0 |
負債總額 | 215.482 | 67.407 | 56.562 | 24.587 |
長期債務總額 | 0.536 | 0.633 | 11.414 | 12.418 |
長期債務 | 0.536 | 0.633 | 11.414 | 12.418 |
其他負債,總計 | 114.681 | 20.116 | 22.049 | 5.485 |
股權 | 485.806 | 542.938 | 242.023 | 76.844 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 448.312 | 201.109 |
普通股 | 0.002 | 0.002 | 0 | 0 |
額外實收資本 | 1125.36 | 943.142 | 7.312 | 2.33 |
留存收益(累計赤字) | -639.556 | -400.08 | -213.601 | -126.595 |
總負債和股東權益 | 701.288 | 610.345 | 298.585 | 101.431 |
已發行普通股總數 | 191.023 | 170.272 | 162.155 | 162.155 |
短期投資 | 0 | 231.446 | 0 | |
商譽,淨額 | 0.801 | 0.801 | 0.801 | |
其他權益,總計 | 0 | -0.126 | 0 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 410.522 | 431.02 | 492.125 | 569.814 | 481.618 |
現金和短期投資 | 387.322 | 405.87 | 473.145 | 549.912 | 454.646 |
現金等價物 | 387.322 | 405.87 | 473.145 | 549.912 | 454.646 |
應收賬款總額,淨額 | 3.164 | 3.051 | 2.057 | 2.753 | 11.635 |
應收賬款 - 貿易,淨額 | 0 | 0 | |||
其他流動資産,總計 | 20.036 | 22.099 | 16.923 | 17.149 | 15.337 |
總資産 | 630.825 | 666.699 | 627.366 | 701.288 | 611.533 |
物業/廠房/設備,總計 - 淨額 | 120.31 | 124.667 | 125.12 | 121.447 | 119.503 |
物業/廠房/設備,總計 - 總額 | 161.157 | 162.267 | 158.754 | 151.562 | 146.555 |
累計折舊,總計 | -40.847 | -37.6 | -33.634 | -30.115 | -27.052 |
無形資産,淨額 | 39.459 | 42.757 | 1.318 | 1.306 | 1.457 |
其他長期資産,總計 | 7.784 | 7.739 | 8.002 | 7.92 | 8.154 |
流動負債總額 | 94.118 | 113.959 | 92.15 | 100.265 | 83.036 |
應付賬款 | 4.265 | 2.086 | 4.247 | 4.586 | 3.89 |
預提費用 | 45.161 | 38.092 | 29.481 | 38.856 | 32.298 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.695 | 0.676 | 0.661 | 0.097 | 0.095 |
其他流動負債,總計 | 43.997 | 73.105 | 57.761 | 56.726 | 46.753 |
負債總額 | 192.858 | 197.736 | 197.191 | 215.482 | 223.499 |
長期債務總額 | 1.126 | 1.155 | 1.179 | 0.536 | 0.561 |
長期債務 | 1.126 | 1.155 | 1.179 | 0.536 | 0.561 |
其他負債,總計 | 95.683 | 78.286 | 103.862 | 114.681 | 139.902 |
股權 | 437.967 | 468.963 | 430.175 | 485.806 | 388.034 |
Redeemable Preferred Stock | |||||
Preferred Stock - Non Redeemable, Net | 0 | ||||
普通股 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 |
額外實收資本 | 1312.59 | 1250.57 | 1135.06 | 1125.36 | 970.096 |
留存收益(累計赤字) | -874.626 | -781.609 | -704.883 | -639.556 | -582.064 |
總負債和股東權益 | 630.825 | 666.699 | 627.366 | 701.288 | 611.533 |
已發行普通股總數 | 215.564 | 202.731 | 192.231 | 191.023 | 174.073 |
短期投資 | 0 | 0 | |||
其他權益,總計 | 0 | 0 | |||
商譽,淨額 | 52.75 | 60.516 | 0.801 | 0.801 | 0.801 |
遞延所得稅 | 1.931 | 4.336 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
淨收入/起跑線 | -239.476 | -186.479 | -87.006 | -61.879 |
經營活動産生的現金 | -83.524 | -158.614 | -45.399 | -57.042 |
經營活動産生的現金 | 11.756 | 8.405 | 4.442 | 3.543 |
非現金物品 | 39.275 | 19.766 | 6.331 | 0.886 |
已付現金利息 | 0.055 | 0.68 | 0.989 | 0.485 |
營運資金的變化 | 104.921 | -0.306 | 30.834 | 0.408 |
投資活動産生的現金 | 193.249 | -271.744 | -8.74 | -3.91 |
資本支出 | -37.059 | -39.798 | -5.831 | -3.91 |
其他投資現金流量項目,總計 | 230.308 | -231.946 | -2.909 | 0 |
融資活動産生的現金 | 154.345 | 458.54 | 246.135 | 120.41 |
融資現金流項目 | 0 | 0 | -0.275 | |
股票的發行(報廢),淨額 | 154.435 | 471.338 | 239.812 | 119.98 |
債務的發行(退還),淨額 | -0.09 | -12.798 | 6.323 | 0.705 |
現金淨變化 | 263.763 | 28.182 | 191.996 | 59.458 |
外彙效應 | -0.307 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -65.327 | -239.476 | -181.984 | -121.539 | -55.979 |
Cash From Operating Activities | -73.316 | -83.524 | -38.776 | 15.765 | 77.388 |
Cash From Operating Activities | 3.728 | 11.756 | 8.542 | 5.553 | 2.767 |
Non-Cash Items | 12.687 | 39.275 | 29.144 | 18.464 | 7.776 |
Cash Interest Paid | 0.013 | 0.055 | 0.042 | 0.028 | 0.014 |
Changes in Working Capital | -24.404 | 104.921 | 105.522 | 113.287 | 122.824 |
Cash From Investing Activities | -5.34 | 193.249 | 201.228 | 148.244 | 143.304 |
Capital Expenditures | -5.175 | -37.059 | -29.08 | -20.817 | -4.342 |
Cash From Financing Activities | 1.922 | 154.345 | 7.089 | 4.752 | 2.084 |
Issuance (Retirement) of Stock, Net | 1.946 | 154.435 | 7.156 | 4.796 | 2.106 |
Issuance (Retirement) of Debt, Net | -0.024 | -0.09 | -0.067 | -0.044 | -0.022 |
Net Change in Cash | -76.736 | 263.763 | 169.541 | 168.761 | 222.776 |
Other Investing Cash Flow Items, Total | -0.165 | 230.308 | 230.308 | 169.061 | 147.646 |
Financing Cash Flow Items | |||||
Foreign Exchange Effects | -0.002 | -0.307 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
41S Rio Grande Street
SALT LAKE CITY
UTAH 84101
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易